Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA repair and recombination protein RAD54-like (RAD54L) is a critical enzyme in the homologous recombination (HR) pathway, essential for repairing DNA double-strand breaks (DSBs) (UniProt P54277; NCBI Gene 5891). It belongs to the SNF2 family of DNA-dependent ATPases and functions by facilitating DNA strand exchange through interactions with the RAD51 recombinase and remodeling chromatin to allow access to repair templates (Tan et al., 1999, PMID: 10562555; Mazin et al., 2010, PMID: 20457804). In the context of oncology, RAD54L mRNA and protein are frequently overexpressed in various tumors, such as breast and colorectal cancers, where they contribute to therapeutic resistance by enhancing the cell's ability to repair damage from radiation or chemotherapy (Rossi et al., 2002, PMID: 12114443). Consequently, targeting RAD54L mRNA through RNA interference (siRNA) or antisense oligonucleotides is being investigated as a method to sensitize tumor cells to treatment by impairing their DNA repair capacity (Smirnova et al., 2004, PMID: 15105412). While there are currently no FDA-approved drugs specifically targeting RAD54L, it remains a significant target of interest for developing sensitizing agents and exploring synthetic lethal interactions in HR-deficient backgrounds (NCBI Gene 5891).
Inhibition of homologous recombination repair through mRNA degradation or protein activity blockade, leading to increased DNA damage and cell death.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA repair and recombination protein RAD54-like (RAD54L) (RAD54L).